Acute pyelonephritis in pregnancy and plasma syndecan-1: evidence of glycocalyx involvement

References

• Hill JB, Sheffield JS, McIntire DD, et al. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105(1):18–23.
   PubMed Web of Science ®Google Scholar
• Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol. 2012;120(3):689–706.
   PubMed Web of Science ®Google Scholar
• Snyder CC, Barton JR, Habli M, et al. Severe sepsis and septic shock in pregnancy: indications for delivery and maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2013;26(5):503–506.
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Lucas MJ, Hankins GD. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol. 1987;156(4):797–807.
   PubMed Web of Science ®Google Scholar
• Amstey MS. Frequency of adult respiratory distress syndrome in pregnant women who have pyelonephritis. Clin Infect Dis. 1992;14(6):1260–1261.
   PubMed Web of Science ®Google Scholar
• Pruett K, Faro S. Pyelonephritis associated with respiratory distress. Obstet Gynecol. 1987;69(3 Pt 2):444–446.
   PubMed Web of Science ®Google Scholar
• Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today. 1999;20(3):114–118.
   PubMedGoogle Scholar
• Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80–86.
   PubMed Web of Science ®Google Scholar
• Naccasha N, Gervasi MT, Chaiworapongsa T, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 2001;185(5):1118–1123.
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17(4):239–245.
   PubMed Web of Science ®Google Scholar
• Nieuwdorp M, Meuwese MC, Mooij HL, et al. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis. 2009;202(1):296–303.
   PubMed Web of Science ®Google Scholar
• Weinbaum S, Cancel LM, Fu BM, et al. The glycocalyx and its role in vascular physiology and vascular related diseases. Cardiovasc Eng Technol. 2021;12(1):37–71.
   PubMed Web of Science ®Google Scholar
• Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16.
   PubMed Web of Science ®Google Scholar
• Nelson A, Berkestedt I, Schmidtchen A, et al. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623–627.
   PubMed Web of Science ®Google Scholar
• Richards JE, Samet RE, Grissom TE. Scratching the surface: endothelial damage in traumatic hemorrhagic shock. Adv Anesth. 2021;39:35–51.
   PubMedGoogle Scholar
• Couchman JR. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol. 2003;4(12):926–937.
   PubMed Web of Science ®Google Scholar
• Yoneda A, Couchman JR. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 2003;22(1):25–33.
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci. 2001;114(Pt 5):853–865.
   PubMed Web of Science ®Google Scholar
• Bode L, Eklund EA, Murch S, et al. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. Am J Physiol Gastrointest Liver Physiol. 2005;288(5):G1015–23.
   PubMed Web of Science ®Google Scholar
• Tarbell JM, Ebong EE. The endothelial glycocalyx: a mechano-sensor and -transducer. Sci Signal. 2008;1(40):pt8.
   PubMed Web of Science ®Google Scholar
• Ali S, Fritchley SJ, Chaffey BT, et al. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology. 2002;12(9):535–543.
   PubMed Web of Science ®Google Scholar
• Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345–359.
   PubMed Web of Science ®Google Scholar
• Saunders S, Jalkanen M, O'Farrell S, et al. Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol. 1989;108(4):1547–1556.
   PubMed Web of Science ®Google Scholar
• Teng YH, Aquino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31(1):3–16.
   PubMed Web of Science ®Google Scholar
• Holzmann MS, Winkler MS, Strunden MS, et al. Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery. Biomark Med. 2018;12(2):119–127.
   PubMed Web of Science ®Google Scholar
• Piotti A, Novelli D, Meessen JMTA, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Crit Care. 2021;25(1):113.
   PubMed Web of Science ®Google Scholar
• Miranda CH, de Carvalho Borges M, Schmidt A, et al. Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome. Atherosclerosis. 2016;247:184–188.
   PubMed Web of Science ®Google Scholar
• Wang JB, Zhang YJ, Zhang Y, et al. Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol. 2013;50(2):111–115.
   PubMed Web of Science ®Google Scholar
• Salmito FT, de Oliveira Neves FM, Meneses GC, et al. Glycocalyx injury in adults with nephrotic syndrome: association with endothelial function. Clin Chim Acta. 2015;447:55–58.
   PubMed Web of Science ®Google Scholar
• Hadlock FP, Harrist RB, Sharman RS, et al. Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol. 1985;151(3):333–337.
   PubMed Web of Science ®Google Scholar
• Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168.
   PubMed Web of Science ®Google Scholar
• Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014;210(3):219.e1-6–219.e6.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Espinoza J, et al. Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med. 2007;20(10):735–744.
   PubMed Web of Science ®Google Scholar
• Hofmann-Kiefer KF, Knabl J, Martinoff N, et al. Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study. Reprod Sci. 2013;20(3):318–325.
   PubMed Web of Science ®Google Scholar
• Szabo S, Xu Y, Romero R, et al. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Arch. 2013;463(3):445–458.
   PubMed Web of Science ®Google Scholar
• Oravecz O, Balogh A, Romero R, et al. Proteoglycans: systems-level insight into their expression in healthy and diseased placentas. IJMS. 2022;23(10):5798.
   Google Scholar
• Gandley RE, Althouse A, Jeyabalan A, et al. Low soluble syndecan-1 precedes preeclampsia. PLoS One. 2016;11(6):e0157608.
   PubMed Web of Science ®Google Scholar
• Crescimanno C, Marzioni D, Paradinas FJ, et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J. Pathol. 1999;189(4):600–608.
   PubMed Web of Science ®Google Scholar
• Lorenzi T, Turi A, Crescimanno C, et al. Syndecan expressions in the human amnion and chorionic plate. Eur J Histochem. 2010;54(4):e42.
   PubMed Web of Science ®Google Scholar
• Jokimaa V, Inki P, Kujari H, et al. Expression of syndecan-1 in human placenta and decidua. Placenta. 1998;19(2-3):157–163.
   PubMed Web of Science ®Google Scholar
• Moore KH, Murphy HA, Chapman H, et al. Syncytialization alters the extracellular matrix and barrier function of placental trophoblasts. Am J Physiol Cell Physiol. 2021;321(4):C694–C703.
   PubMed Web of Science ®Google Scholar
• Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007;39(3):505–528.
   PubMed Web of Science ®Google Scholar
• Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol. 2000;279(6):H2815–23.
   PubMed Web of Science ®Google Scholar
• Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009;104(1):78–89.
   PubMed Web of Science ®Google Scholar
• Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004;286(5):H1672–80.
   PubMed Web of Science ®Google Scholar
• Sullivan RC, Rockstrom MD, Schmidt EP, et al. Endothelial glycocalyx degradation during sepsis: causes and consequences. Matrix Biol Plus. 2021;12:100094.
   PubMedGoogle Scholar
• Sallisalmi M, Tenhunen J, Yang R, et al. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol Scand. 2012;56(3):316–322.
   PubMed Web of Science ®Google Scholar
• Ostrowski SR, Gaïni S, Pedersen C, et al. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study. J Crit Care. 2015;30(1):90–96.
   PubMed Web of Science ®Google Scholar
• Docheva N, Romero R, Chaemsaithong P, et al. The profiles of soluble adhesion molecules in the “great obstetrical syndromes”. J Matern Fetal Neonatal Med. 2019;32(13):2113–2136.
   PubMed Web of Science ®Google Scholar
• Kornacki J, Wirstlein P, Wender-Ozegowska E. Markers of endothelial injury and dysfunction in early- and late-onset preeclampsia. Life (Basel.). 2020;10(10):239.
   PubMed Web of Science ®Google Scholar
• Kornacki J, Wirstlein P, Wender-Ozegowska E. Serum levels of soluble FMS-like tyrosine kinase 1 and endothelial glycocalyx components in early- and late-onset preeclampsia. J Matern Fetal Neonatal Med. 2022;35:7466–7470.
   PubMed Web of Science ®Google Scholar
• Alici Davutoğlu E, Akkaya Firat A, Ozel A, et al. Evaluation of maternal serum hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia. J Matern Fetal Neonatal Med. 2018;31(15):1976–1982.
   PubMed Web of Science ®Google Scholar
• Kuessel L, Husslein H, Montanari E, et al. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study. Clin Chem Lab Med. 2019;58(1):50–58.
   PubMed Web of Science ®Google Scholar
• Wing DA, Park AS, Debuque L, et al. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol. 2000;182(6):1437–1440.
   PubMed Web of Science ®Google Scholar
• MacMillan MC, Grimes DA. The limited usefulness of urine and blood cultures in treating pyelonephritis in pregnancy. Obstet Gynecol. 1991. 78(5 Pt 1):745–748.
   Google Scholar
• Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015;28(14):1621–1632.
   PubMed Web of Science ®Google Scholar